NCT01814683View on ClinicalTrials.gov

IMPROV (Improving the Radical Cure of Vivax Malaria)

NACompletedINTERVENTIONAL
Enrollment

2,388

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Uncomplicated Vivax Malaria
Interventions
DRUG

Primaquine

14 days of supervised primaquine (7mg/kg total dose) administered once per day (0.5 mg/kg).

DRUG

Primaquine

7 days of supervised primaquine (7mg/kg total dose) administered once per day (1.0 mg/kg OD) followed by 7 days of placebo.

DRUG

Placebo

14 days placebo.

Trial Locations (8)

20156

Tanjong Leidong District Health Center, Medan

Unknown

Provincial Malaria & Leishmania control program (PMLCP) Nangarhar, Jalalabad

Laghman Provincial Hospital, Laghmān

Metahara Sugar Factory Hospital, Metehara

Arba Minch Hospital, Ārba Minch

Hanura Health Center, Bandar Lampung

Dak O and Bu Gia Map Health Communes, Bình Phước

Krong Pa Hospital, Krông Pa

All Listed Sponsors
collaborator

Menzies School of Health Research

OTHER

lead

University of Oxford

OTHER

NCT01814683 - IMPROV (Improving the Radical Cure of Vivax Malaria) | Biotech Hunter | Biotech Hunter